← back to search

Andrea Ferrari

University of Milan · IT
Area of research
Pulmonary and Respiratory Medicine · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Childhood Cancer Survivors' Quality of Life, Neuroblastoma Research and Treatments, and Bone Tumor Diagnosis and Treatments.
h-index
84
citations
30,972
works
817
NIH funding
primary concept
Medicine
email

Recent publications

European standard clinical practice recommendations for children and adolescents with Rhabdomyosarcoma a joint EpSSG, CWS and ERN PaedCan project
EJC Paediatric Oncology 2025cited by 6position: middledoi
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)
Lung Cancer 2025cited by 4position: middledoi
Current Management of Desmoid Tumors
JAMA Oncology 2024cited by 73position: middledoi
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram
Cancer 2024cited by 21position: middledoi
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
European Journal of Cancer 2024cited by 18position: middledoi
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
Cancer Treatment Reviews 2024cited by 13position: middledoi
A joint international consensus statement for measuring quality of survival for patients with childhood cancer
Nature Medicine 2023cited by 50position: middledoi
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study
Journal of Clinical Oncology 2023cited by 47position: middledoi
Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles
Modern Pathology 2023cited by 23position: middledoi
The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)
Cancer Medicine 2023cited by 19position: middledoi
Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group
Cancer 2023cited by 13position: firstdoi
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
Pediatric Radiology 2023cited by 10position: middledoi
Inflammatory Myofibroblastic Tumor With <i>ROS1</i> Gene Fusions in Children and Young Adolescents
JCO Precision Oncology 2023cited by 5position: middledoi
Metastatic Rhabdomyosarcoma: Results of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study
Journal of Clinical Oncology 2022cited by 56position: middledoi
The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium
European Journal of Cancer 2022cited by 30position: firstdoi
Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study
The Lancet Child & Adolescent Health 2022cited by 27position: firstdoi
Long‐term results from the multicentric European randomized phase 3 trial CWS/RMS‐96 for localized high‐risk soft tissue sarcoma in children, adolescents, and young adults
Pediatric Blood & Cancer 2022cited by 26position: middledoi
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations
Journal of Pediatric Hematology/Oncology 2022cited by 18position: middledoi
Metacarpophalangeal joint hyperextension in rhizartrosis: is surgical correction necessary?
PubMed 2022cited by 1position: middledoi
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology 2021cited by 955position: middledoi
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology 2021cited by 550position: middledoi
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology 2021cited by 439position: middledoi
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Cancer Discovery 2021cited by 195position: middledoi
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
ESMO Open 2021cited by 179position: middledoi
Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
The Lancet Child & Adolescent Health 2021cited by 52position: firstdoi
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Pediatric Blood & Cancer 2021cited by 43position: middledoi
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) – RMS2005 study
European Journal of Cancer 2021cited by 42position: middledoi
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Pediatric Blood & Cancer 2021cited by 42position: middledoi
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience
European Journal of Cancer 2021cited by 36position: middledoi
Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements
Pediatric Blood & Cancer 2021cited by 33position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Gianni Bisogno · St. Jude Children's Research Hospital66 papers (2012–2025)Daniel Orbach · Institut Curie47 papers (2012–2025) · 27 papers (2012–2024)Michela Casanova · Fondazione IRCCS Istituto Nazionale dei Tumori23 papers (2012–2023)Giovanni Cecchetto · University of Padua22 papers (2012–2022)Johannes H. M. Merks · Utrecht University21 papers (2013–2025)Rita Alaggio · Bambino Gesù Children's Hospital20 papers (2012–2025) · 19 papers (2017–2025)Dominik T. Schneider · Klinikum Dortmund17 papers (2012–2025)Ines B. Brecht · University Children's Hospital Tübingen16 papers (2012–2025)Anna Kelsey · Royal Manchester Children's Hospital16 papers (2013–2025) · 16 papers (2012–2025)Ilaria Zanetti · University of Padua15 papers (2017–2023)Julia Chisholm · Royal Marsden NHS Foundation Trust15 papers (2016–2025)Meriel Jenney · Cardiff and Vale University Health Board15 papers (2014–2024)Bernadette Brennan · Royal Manchester Children's Hospital15 papers (2012–2023) · 14 papers (2012–2021)Soledad Gallego · Hebron University13 papers (2016–2023)Jan Godziński · Medical University of Silesia13 papers (2012–2025)Christophe Bergeron · Université Claude Bernard Lyon 112 papers (2013–2021)